Literature DB >> 26564036

A Novel Member of Chitinophagaceae Isolated from a Human Peritoneal Tumor.

Alexander S Lo1, D Scott Merrell1, Haiyan Lei2, Armando Sardi3, Thomas McAvoy4, Traci L Testerman5.   

Abstract

Peritoneal tumors from a rare malignancy, pseudomyxoma peritonei, frequently contain bacteria. Evidence suggests that tumor-associated bacteria contribute to pseudomyxoma peritonei development and/or progression. One unique isolate (PMP191F) was characterized via whole-genome sequencing using the Illumina MiSeq platform. PMP191F shows similarities to the Chitinophaga, Niastella, and Flavitalea genera.
Copyright © 2015 Lo et al.

Entities:  

Year:  2015        PMID: 26564036      PMCID: PMC4972772          DOI: 10.1128/genomeA.01297-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Pseudomyxoma peritonei (PMP) is a rare malignancy of the peritoneum believed to originate from a mucinous appendiceal cyst adenoma, which invades the intraperitoneal cavity (1). Previously, the presence of enteric bacteria, including Helicobacter pylori, has been identified in PMP (2). Additionally, Gilbreath et al. (3) identified a core microbiome present in PMP tumors that is conserved among examined patients. Moreover, a recent study by Semino-Mora et al. (4) suggested higher bacterial density and higher expression of the MUC2 mucin associated with more malignant forms of PMP. It was further shown that the treatment of patients with antibiotics targeting H. pylori prior to cytoreductive surgery reduces the peritoneal bacterial density and decreases nuclear β-catenin, a known biomarker of carcinogenesis. Additionally, 5-year survival data suggest increased survivability among antibiotic-treated patients (3). To further understand the relationship between bacteria and PMP, we have sought to isolate, identify, and characterize some of the bacterial species found in PMP samples. Isolate PMP191F showed unique characteristics compared with other PMP isolates and was further characterized. Bacteria from PMP samples collected under an institutional review board (IRB)-approved protocol were initially grown in Ham’s F-12 medium supplemented with 2% fetal bovine serum. Bacteria were subsequently isolated as single colonies on blood agar plates. Genomic DNA was extracted from the isolates for initial PCR amplification of the 16S rRNA gene. The 16S sequence of PMP191F was found to have 95% identity with an unsequenced Chitinophaga species and Flavitalea populi strain HY-50R (accession no. HM130561.1). PMP191F genomic DNA was subjected to DNA library construction using the Illumina MiSeq platform and sequenced with a 2.250-bp paired-end sequencing mode. A total of 17.8 million quality reads of 225 bp average length were assembled into 66 contigs (N50, 269 kbp) using the CLC Genomics Workbench (version 6.0; CLC bio). These contigs yielded a total genome size of 6,452,579 bp and a G+C content of 43.4%. Functional annotation was performed with Rapid Annotations using Subsystems Technology (RAST) (5), which predicted 5,577 coding regions with 380 subsystems and 46 tRNAs. Several genes were predicted to impart antibiotic resistance, including β-lactamase and multiple efflux pumps. Chitinophaga pinensis was identified as the closest neighbor, with a RAST score of 532. Comparative analysis of the genome contents using progressiveMauve (6) of previously identified close species estimated 90.3% homology with C. pinensis (accession no. NC_013132.1) and 84.7% with Niastella koreensis (accession no. CP003178.1); however, 16S sequence-based phylogeny places PMP191F closer to Niastella than to Chitinophaga. For this reason, it is unclear whether PMP191F belongs to any of the named genera. Phenotypic, biochemical, and metabolic characterizations were performed using the Biolog ID system (Biolog, Inc., Hayward, CA, USA). Phenotypic analysis using a Biolog assay suggested a relationship to Flavobacterium johnsoniae, with a probability and similarity of 0.59. The Biolog assay also revealed resistance to rifamycin and lincomycin. Given the association between peritoneal bacterial load and inflammatory markers, as well as the improved survival in antibiotic-treated PMP patients (2), we propose PMP191F as a novel bacterial species that has potentially significant associations with PMP.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. LGYU00000000. The version described in this paper is the first version, LGYU01000000.
  6 in total

1.  Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution.

Authors:  Cristina Semino-Mora; Traci L Testerman; Hui Liu; Jeannette M Whitmire; Kimberley Studeman; Yali Jia; Thomas J McAvoy; Jennifer Francis; Carol Nieroda; Armando Sardi; D Scott Merrell; Andre Dubois
Journal:  Clin Cancer Res       Date:  2013-06-06       Impact factor: 12.531

2.  progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement.

Authors:  Aaron E Darling; Bob Mau; Nicole T Perna
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

3.  Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.

Authors:  Cristina Semino-Mora; Hui Liu; Thomas McAvoy; Carol Nieroda; Kimberley Studeman; Armando Sardi; Andre Dubois
Journal:  Ann Surg Oncol       Date:  2008-02-26       Impact factor: 5.344

4.  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.

Authors:  R M Smeenk; M L F van Velthuysen; V J Verwaal; F A N Zoetmulder
Journal:  Eur J Surg Oncol       Date:  2007-05-23       Impact factor: 4.424

5.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

6.  A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei.

Authors:  Jeremy J Gilbreath; Cristina Semino-Mora; Christopher J Friedline; Hui Liu; Kip L Bodi; Thomas J McAvoy; Jennifer Francis; Carol Nieroda; Armando Sardi; Andre Dubois; David W Lazinski; Andrew Camilli; Traci L Testerman; D Scott Merrell
Journal:  Orphanet J Rare Dis       Date:  2013-07-12       Impact factor: 4.123

  6 in total
  2 in total

Review 1.  The Role of Microorganisms in Appendiceal Pseudomyxoma Peritonei: A Review.

Authors:  Yekaterina Khamzina; Mary Caitlin King; Carol Nieroda; D Scott Merrell; Armando Sardi; Vadim Gushchin
Journal:  Curr Oncol       Date:  2022-05-16       Impact factor: 3.109

2.  Parapseudoflavitalea muciniphila gen. nov., sp. nov., a member of the family Chitinophagaceae isolated from a human peritoneal tumour and reclassification of Pseudobacter ginsenosidimutans as Pseudoflavitalea ginsenosidimutans comb. nov.

Authors:  Paul A Lawson; Nisha B Patel; Ahmed Mohammed; Edward R B Moore; Alexander S Lo; Armando Sardi; Jeffrey M Davis; D Annie Doyle; Yvonne Hui; Traci Testerman
Journal:  Int J Syst Evol Microbiol       Date:  2020-06-05       Impact factor: 2.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.